In NSCLC, miR-21 silencing reversed multidrug resistance and subsequently reduced Akt phosphorylation to modulate the expression levels of the transcriptional factor E2F-1 and Twist. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.